[
  {
    "title": "A股异动 | 贝瑞基因(000710.SZ)跌约4% 宏瓴并购拟减持不超6%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/19100137221645.shtml",
    "datetime": "2022-12-19 10:01:16",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购拟减持不超6%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/16222937219720.shtml",
    "datetime": "2022-12-16 22:29:05",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：控股股东高扬质押的3050万股展期",
    "href": "http://stock.jrj.com.cn/2022/11/01214137104834.shtml",
    "datetime": "2022-11-01 21:41:08",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：控股股东高扬及其一致行动人近日合计减持1.11%股份",
    "href": "http://stock.jrj.com.cn/2022/11/01194537104441.shtml",
    "datetime": "2022-11-01 19:45:26",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)第三季度净利242.07万元 同比增长175.95%",
    "href": "http://stock.jrj.com.cn/2022/10/28195537095279.shtml",
    "datetime": "2022-10-28 19:55:44",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：2022年三季报披露时间推迟至10月29日",
    "href": "http://stock.jrj.com.cn/2022/10/17205337061899.shtml",
    "datetime": "2022-10-17 20:53:19",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：延期至10月29日披露第三季度报告",
    "href": "http://stock.jrj.com.cn/2022/10/17194437061597.shtml",
    "datetime": "2022-10-17 19:44:50",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购减持期过半未减持",
    "href": "http://stock.jrj.com.cn/2022/09/15164636997444.shtml",
    "datetime": "2022-09-15 16:46:13",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：子公司近日获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/09/09161136986300.shtml",
    "datetime": "2022-09-09 16:11:38",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：聘任张松清为财务总监",
    "href": "http://stock.jrj.com.cn/2022/09/09160436986258.shtml",
    "datetime": "2022-09-09 16:04:42",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2022年上半年亏损1861.49万同比由盈转亏 基础科研服务收入下降",
    "href": "http://stock.jrj.com.cn/2022/08/12211136896662.shtml",
    "datetime": "2022-08-12 21:11:24",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)上半年净亏损1861.49万元 同比转亏",
    "href": "http://stock.jrj.com.cn/2022/08/12173836895636.shtml",
    "datetime": "2022-08-12 17:38:59",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2022年上半年预计亏损1800万 同比由盈转亏 基础科研服务收入下降",
    "href": "http://stock.jrj.com.cn/2022/07/15113236815187.shtml",
    "datetime": "2022-07-15 11:32:09",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)上半年预亏1800万元 同比转亏",
    "href": "http://stock.jrj.com.cn/2022/07/14172936811774.shtml",
    "datetime": "2022-07-14 17:29:38",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：全资子公司取得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/06/13154636724074.shtml",
    "datetime": "2022-06-13 15:46:26",
    "code": "000710"
  },
  {
    "title": "大股东再计划减持2000万股 贝瑞基因业绩首亏后或面临偿债压力",
    "href": "http://stock.jrj.com.cn/2022/05/27082436683506.shtml",
    "datetime": "2022-05-27 08:24:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购拟减持不超6%的股份",
    "href": "http://stock.jrj.com.cn/2022/05/25193136678626.shtml",
    "datetime": "2022-05-25 19:31:02",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：股东宏瓴并购减持到期未减持",
    "href": "http://stock.jrj.com.cn/2022/05/11182336635118.shtml",
    "datetime": "2022-05-11 18:23:43",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2022年第一季度亏损1192.84万同比由盈转亏 财务费用增长",
    "href": "http://stock.jrj.com.cn/2022/04/15135236343308.shtml",
    "datetime": "2022-04-15 13:52:44",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2021年亏损1亿：第三大业务线收入增速超40% 应收账款占营收比例达77%",
    "href": "http://stock.jrj.com.cn/2022/04/15113136342449.shtml",
    "datetime": "2022-04-15 11:31:46",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2021年亏损1.11亿同比由盈转亏 产品检测服务价格呈下降",
    "href": "http://stock.jrj.com.cn/2022/04/15111036342340.shtml",
    "datetime": "2022-04-15 11:10:44",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：一季度净亏损1192.84万元 同比转亏",
    "href": "http://stock.jrj.com.cn/2022/04/15090236341306.shtml",
    "datetime": "2022-04-15 09:02:48",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)2021年度净亏损1.11亿元 同比转亏",
    "href": "http://stock.jrj.com.cn/2022/04/15085836341274.shtml",
    "datetime": "2022-04-15 08:58:55",
    "code": "000710"
  },
  {
    "title": "【龙虎榜】贝瑞基因4月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/04/14180036336007.shtml",
    "datetime": "2022-04-14 18:00:21",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：减持期过半 宏瓴并购尚未减持股份",
    "href": "http://stock.jrj.com.cn/2022/02/14163334344786.shtml",
    "datetime": "2022-02-14 16:33:12",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：减持期过半 君睿祺已减持1.03%股份",
    "href": "http://stock.jrj.com.cn/2022/01/11195034147352.shtml",
    "datetime": "2022-01-11 19:50:42",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：控股股东及其一致行动人已减持3.3135%股份",
    "href": "http://stock.jrj.com.cn/2022/01/05203934126314.shtml",
    "datetime": "2022-01-05 20:39:55",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：控股股东及其一致行动人解除质押930万股",
    "href": "http://stock.jrj.com.cn/2022/01/05203734126308.shtml",
    "datetime": "2022-01-05 20:37:21",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：子公司地中海贫血基因检测试剂盒（单分子测序法）通过注册检验",
    "href": "http://stock.jrj.com.cn/2021/12/27135234070015.shtml",
    "datetime": "2021-12-27 13:52:36",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：全资子公司检测试剂盒通过注册检验",
    "href": "http://stock.jrj.com.cn/2021/12/27114734069469.shtml",
    "datetime": "2021-12-27 11:47:39",
    "code": "000710"
  },
  {
    "title": "A股异动 | 贝瑞基因(000710.SZ)跌近7% 控股股东及其一致行动人拟协议转让2.6226%的股份",
    "href": "http://stock.jrj.com.cn/2021/12/24135134057169.shtml",
    "datetime": "2021-12-24 13:51:36",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：控股股东及其一致行动人拟向王天一转让2.62%股份",
    "href": "http://stock.jrj.com.cn/2021/12/23172834053243.shtml",
    "datetime": "2021-12-23 17:28:57",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：控股股东及其一致行动人拟协议转让2.6226%的股份",
    "href": "http://stock.jrj.com.cn/2021/12/23172334053229.shtml",
    "datetime": "2021-12-23 17:23:52",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：子公司产品通过医疗器械注册检验",
    "href": "http://stock.jrj.com.cn/2021/12/21213234043414.shtml",
    "datetime": "2021-12-21 21:32:08",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：胎儿染色体拷贝数变异检测试剂盒通过医疗器械注册检验",
    "href": "http://stock.jrj.com.cn/2021/12/21195634042983.shtml",
    "datetime": "2021-12-21 19:56:51",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2021年预计亏损6000万-9000万同比由盈转亏 市场竞争加剧使检测价格下降",
    "href": "http://stock.jrj.com.cn/2021/12/10051133992054.shtml",
    "datetime": "2021-12-10 05:11:10",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺5月25日以来共减持1.0084%股份",
    "href": "http://stock.jrj.com.cn/2021/11/29193433939197.shtml",
    "datetime": "2021-11-29 19:34:04",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：子公司获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2021/11/25194933920097.shtml",
    "datetime": "2021-11-25 19:49:30",
    "code": "000710"
  },
  {
    "title": "业绩低迷 贝瑞基因大股东纷纷减持 研发投入是“亮点”",
    "href": "http://stock.jrj.com.cn/2021/11/05081833815838.shtml",
    "datetime": "2021-11-05 08:18:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：减持期满 君睿祺已减持79.5万股",
    "href": "http://stock.jrj.com.cn/2021/11/03211833809778.shtml",
    "datetime": "2021-11-03 21:18:45",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2021/11/03205233809691.shtml",
    "datetime": "2021-11-03 20:52:44",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2021/10/20165433722226.shtml",
    "datetime": "2021-10-20 16:54:09",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：福建和瑞B轮股东君联景明拟追加对B轮投资额5000万元",
    "href": "http://stock.jrj.com.cn/2021/10/18212733712824.shtml",
    "datetime": "2021-10-18 21:27:25",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：聘任公司董事长高扬为总经理",
    "href": "http://stock.jrj.com.cn/2021/10/07204633647666.shtml",
    "datetime": "2021-10-07 20:46:03",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺已累计减持4.55%的股份 持股降至5%",
    "href": "http://stock.jrj.com.cn/2021/09/24172633510628.shtml",
    "datetime": "2021-09-24 17:26:43",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺减持期过半 累计减持75万股",
    "href": "http://stock.jrj.com.cn/2021/09/22173733499451.shtml",
    "datetime": "2021-09-22 17:37:49",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：“孕妇外周血胎儿游离DNA产前筛查”纳入北京市医保",
    "href": "http://stock.jrj.com.cn/2021/09/02194433375564.shtml",
    "datetime": "2021-09-02 19:44:56",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)半年度净利润3123.23万元 同比下降73.41%",
    "href": "http://stock.jrj.com.cn/2021/08/29221333341846.shtml",
    "datetime": "2021-08-29 22:13:32",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2021年半年度净利3123.23万元 同比净利减少73.41%",
    "href": "http://stock.jrj.com.cn/2021/08/29193733341286.shtml",
    "datetime": "2021-08-29 19:37:40",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：减持期过半 宏瓴并购尚未减持股份",
    "href": "http://stock.jrj.com.cn/2021/07/20215033126151.shtml",
    "datetime": "2021-07-20 21:50:39",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：持股5.22%股东君睿祺拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2021/07/12191233083886.shtml",
    "datetime": "2021-07-12 19:12:18",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：控股股东质押的26万股延期购回及解押318万股",
    "href": "http://stock.jrj.com.cn/2021/07/02220033035848.shtml",
    "datetime": "2021-07-02 22:00:05",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：持股5%以上股东君睿祺累计减持约2.0902%股份 减持计划实施期限已届满",
    "href": "http://stock.jrj.com.cn/2021/06/30155633022071.shtml",
    "datetime": "2021-06-30 15:56:44",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺减持期届满 累计减持2.09%股份",
    "href": "http://stock.jrj.com.cn/2021/06/30120233020895.shtml",
    "datetime": "2021-06-30 12:02:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购解除质押1020万股",
    "href": "http://stock.jrj.com.cn/2021/06/08202132895393.shtml",
    "datetime": "2021-06-08 20:21:57",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺已减持1.0013%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/24191532811978.shtml",
    "datetime": "2021-05-24 19:15:19",
    "code": "000710"
  },
  {
    "title": "基因测序龙头贝瑞基因2020年预盈超2亿元 业务拓展至多元变现领域",
    "href": "http://stock.jrj.com.cn/2021/04/29173732480751.shtml",
    "datetime": "2021-04-29 17:37:21",
    "code": "000710"
  },
  {
    "title": "贝瑞基因涨停医疗板块个股分化，21只医疗股一季度利润同比翻倍",
    "href": "http://stock.jrj.com.cn/2021/04/29120132479135.shtml",
    "datetime": "2021-04-29 12:01:52",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)上半年净利预降49%-66%",
    "href": "http://stock.jrj.com.cn/2021/04/28183732473077.shtml",
    "datetime": "2021-04-28 18:37:04",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)一季度净利降65.95%至2124.25万元",
    "href": "http://stock.jrj.com.cn/2021/04/28183232473051.shtml",
    "datetime": "2021-04-28 18:32:42",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)2020年净利降46.07%至2.11亿元",
    "href": "http://stock.jrj.com.cn/2021/04/28182832473032.shtml",
    "datetime": "2021-04-28 18:28:56",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2020年度净利下滑46.07% 各项防疫成本大幅上升",
    "href": "http://stock.jrj.com.cn/2021/04/15162832379922.shtml",
    "datetime": "2021-04-15 16:28:51",
    "code": "000710"
  },
  {
    "title": "业绩不佳 贝瑞基因(000710.SZ)封跌停板",
    "href": "http://stock.jrj.com.cn/2021/04/15102832377838.shtml",
    "datetime": "2021-04-15 10:28:02",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)一季度净利润预降52%-68%",
    "href": "http://stock.jrj.com.cn/2021/04/14204032373555.shtml",
    "datetime": "2021-04-14 20:40:21",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：公司提供核酸检测服务 并未生产试剂盒",
    "href": "http://stock.jrj.com.cn/2021/04/07160732325439.shtml",
    "datetime": "2021-04-07 16:07:16",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：减持期满 宏瓴并购尚未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/03/30023732244318.shtml",
    "datetime": "2021-03-30 02:37:25",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购拟减持不超6%的股份",
    "href": "http://stock.jrj.com.cn/2021/03/30023632244317.shtml",
    "datetime": "2021-03-30 02:36:04",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺减持期过半 累计减持278.04万股",
    "href": "http://stock.jrj.com.cn/2021/03/22200632196363.shtml",
    "datetime": "2021-03-22 20:06:34",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：就终止A股定增事项 收到终止审查通知书",
    "href": "http://stock.jrj.com.cn/2021/03/09183932098957.shtml",
    "datetime": "2021-03-09 18:39:08",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：终止定增事项及撤回申请文件",
    "href": "http://stock.jrj.com.cn/2021/02/26160832033143.shtml",
    "datetime": "2021-02-26 16:08:50",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：子公司获高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2021/02/22194732007593.shtml",
    "datetime": "2021-02-22 19:47:14",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购减持期过半 尚未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/02/19191331993970.shtml",
    "datetime": "2021-02-19 19:13:43",
    "code": "000710"
  },
  {
    "title": "【龙虎榜】贝瑞基因2月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/02/03180031844133.shtml",
    "datetime": "2021-02-03 18:00:54",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2020年度预盈约2亿元 肿瘤检测布局取得阶段性进展",
    "href": "http://stock.jrj.com.cn/2021/01/29221331811930.shtml",
    "datetime": "2021-01-29 22:13:00",
    "code": "000710"
  },
  {
    "title": "【龙虎榜】贝瑞基因1月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/22180131746193.shtml",
    "datetime": "2021-01-22 18:01:02",
    "code": "000710"
  },
  {
    "title": "贝瑞基因收警示函 未遵守会计准则小比例多计2年净利",
    "href": "http://stock.jrj.com.cn/2021/01/11183431671518.shtml",
    "datetime": "2021-01-11 18:34:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：公司在福建兴建的大数据中心产业园正在建设中一期项目主体工程已封顶",
    "href": "http://stock.jrj.com.cn/2020/12/30164931605505.shtml",
    "datetime": "2020-12-30 16:49:39",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]你好2021",
    "href": "http://stock.jrj.com.cn/2020/12/30000031605957.shtml",
    "datetime": "2020-12-30 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因董事长高扬：国内外技术同级竞争 提质增效“六字秘诀”",
    "href": "http://stock.jrj.com.cn/2020/12/29014331589589.shtml",
    "datetime": "2020-12-29 01:43:29",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)拟转让涉房业务控股子公司股权",
    "href": "http://stock.jrj.com.cn/2020/12/09183231450541.shtml",
    "datetime": "2020-12-09 18:32:38",
    "code": "000710"
  },
  {
    "title": "股东减持 业绩大降 贝瑞基因业绩颓势何时止？",
    "href": "http://stock.jrj.com.cn/2020/12/08063931436404.shtml",
    "datetime": "2020-12-08 06:39:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：回购期届满 已累计回购1.1018%的股份",
    "href": "http://stock.jrj.com.cn/2020/12/07202531432996.shtml",
    "datetime": "2020-12-07 20:25:25",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：持股7.31%的君睿祺拟减持不超4%的股份",
    "href": "http://stock.jrj.com.cn/2020/12/07202331432976.shtml",
    "datetime": "2020-12-07 20:23:22",
    "code": "000710"
  },
  {
    "title": "贝瑞基因股东拟减持不超3%公司股份",
    "href": "http://stock.jrj.com.cn/2020/12/05074531412794.shtml",
    "datetime": "2020-12-05 07:45:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：宏瓴并购拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2020/12/04183831409664.shtml",
    "datetime": "2020-12-04 18:38:36",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：君睿祺减持期届满 累计减持722.77万股",
    "href": "http://stock.jrj.com.cn/2020/12/03200131402308.shtml",
    "datetime": "2020-12-03 20:01:23",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：约1.2337亿股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2020/12/02181531393758.shtml",
    "datetime": "2020-12-02 18:15:22",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]2020年北京市科学技术奖提名公示内容(公告栏)",
    "href": "http://stock.jrj.com.cn/2020/11/05000031223202.shtml",
    "datetime": "2020-11-05 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2020年前三季度净利1.51亿下滑51.87% 投资收益同比下滑",
    "href": "http://stock.jrj.com.cn/2020/11/01170731184262.shtml",
    "datetime": "2020-11-01 17:07:50",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15081031056964.shtml",
    "datetime": "2020-10-15 08:10:31",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2020年前三季度净利1.5亿-1.6亿同比下降 医学检测收入下降",
    "href": "http://stock.jrj.com.cn/2020/10/14214831054075.shtml",
    "datetime": "2020-10-14 21:48:44",
    "code": "000710"
  },
  {
    "title": "三季度业绩降幅企稳 贝瑞基因多款肿瘤筛检新品成功面市",
    "href": "http://stock.jrj.com.cn/2020/10/14204831055168.shtml",
    "datetime": "2020-10-14 20:48:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)前三季度净利润预降48.94%-52.14%",
    "href": "http://stock.jrj.com.cn/2020/10/14201331053532.shtml",
    "datetime": "2020-10-14 20:13:38",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：控股股东一致行动人侯颖解押921万股",
    "href": "http://stock.jrj.com.cn/2020/09/28210630855187.shtml",
    "datetime": "2020-09-28 21:06:22",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]和瑞基因公布多瘤种早筛早诊路线图",
    "href": "http://stock.jrj.com.cn/2020/09/23000030850966.shtml",
    "datetime": "2020-09-23 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因携手中国抗癫痫协会助力癫痫精准诊疗",
    "href": "http://stock.jrj.com.cn/2020/09/04000031031130.shtml",
    "datetime": "2020-09-04 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因(000710.SZ)：截至8月底累计耗资1.6亿元回购1.1018%股份",
    "href": "http://stock.jrj.com.cn/2020/09/03201630670375.shtml",
    "datetime": "2020-09-03 20:16:27",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2020年上半年净利1.17亿下滑53.17% 医院诊疗科室就诊人数下降",
    "href": "http://stock.jrj.com.cn/2020/08/31184330644769.shtml",
    "datetime": "2020-08-31 18:43:11",
    "code": "000710"
  },
  {
    "title": "肿瘤检测收获期来临 贝瑞基因定增加码产业链布局",
    "href": "http://stock.jrj.com.cn/2020/08/31112230641996.shtml",
    "datetime": "2020-08-31 11:22:28",
    "code": "000710"
  },
  {
    "title": "贝瑞基因上半年营收略降 肿瘤检测布局进一步完善",
    "href": "http://stock.jrj.com.cn/2020/08/30220730624124.shtml",
    "datetime": "2020-08-30 22:07:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：上半年实现净利润1.17亿元 肝癌早筛产品落地",
    "href": "http://stock.jrj.com.cn/2020/08/30175930623221.shtml",
    "datetime": "2020-08-30 17:59:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]莱思宁,肝癌早筛基因检测服务上市",
    "href": "http://stock.jrj.com.cn/2020/08/21000030557960.shtml",
    "datetime": "2020-08-21 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因携手新格元打造多元化单细胞测序生态圈",
    "href": "http://stock.jrj.com.cn/2020/08/20000030675419.shtml",
    "datetime": "2020-08-20 00:00:00",
    "code": "000710"
  },
  {
    "title": "三省市联合推进带量采购 贝瑞基因拟定增21亿元加强基因测序布局 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/14182630500543.shtml",
    "datetime": "2020-08-14 18:26:50",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：21亿元定增加码主业 深化基因测序领域布局",
    "href": "http://stock.jrj.com.cn/2020/08/14103630497628.shtml",
    "datetime": "2020-08-14 10:36:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因拟募资不超过21亿元 现涨超4%",
    "href": "http://stock.jrj.com.cn/2020/08/14100530497388.shtml",
    "datetime": "2020-08-14 10:05:34",
    "code": "000710"
  },
  {
    "title": "贝瑞基因拟定增21亿元 加码基因检测主业",
    "href": "http://stock.jrj.com.cn/2020/08/14074230496481.shtml",
    "datetime": "2020-08-14 07:42:59",
    "code": "000710"
  },
  {
    "title": "贝瑞基因拟定增募资不超过21.36亿元",
    "href": "http://stock.jrj.com.cn/2020/08/14040630495149.shtml",
    "datetime": "2020-08-14 04:06:25",
    "code": "000710"
  },
  {
    "title": "[加急]下周即将解禁17.5亿股 贝瑞基因解禁市值近60亿",
    "href": "http://stock.jrj.com.cn/2020/08/09100030456118.shtml",
    "datetime": "2020-08-09 10:00:59",
    "code": "000710"
  },
  {
    "title": "遭大股东减持2000万股 贝瑞基因业绩下滑质押1.1亿股股份",
    "href": "http://stock.jrj.com.cn/2020/08/07081230448001.shtml",
    "datetime": "2020-08-07 08:12:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因股东君睿祺合计减持1059万股 套现约7.65亿元",
    "href": "http://stock.jrj.com.cn/2020/08/04224530426577.shtml",
    "datetime": "2020-08-04 22:45:14",
    "code": "000710"
  },
  {
    "title": "【龙虎榜】贝瑞基因8月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/04180730425063.shtml",
    "datetime": "2020-08-04 18:07:25",
    "code": "000710"
  },
  {
    "title": "【龙虎榜】贝瑞基因7月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/30180130386273.shtml",
    "datetime": "2020-07-30 18:01:01",
    "code": "000710"
  },
  {
    "title": "7天4涨停！错过核酸检测的贝瑞基因市值暴增200亿 子公司“654大Panel”进击千亿市场成杀手锏？",
    "href": "http://stock.jrj.com.cn/2020/07/30175330386211.shtml",
    "datetime": "2020-07-30 17:53:20",
    "code": "000710"
  },
  {
    "title": "医疗行业大幅拉升 博辉创新涨停。贝瑞基因、心脉医疗等多股强势上涨",
    "href": "http://stock.jrj.com.cn/2020/07/29100530370999.shtml",
    "datetime": "2020-07-29 10:05:33",
    "code": "000710"
  },
  {
    "title": "【龙虎榜】贝瑞基因7月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/23180430325245.shtml",
    "datetime": "2020-07-23 18:04:30",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]新品丨和瑞基因大Panel检测(654基因)上市!",
    "href": "http://stock.jrj.com.cn/2020/07/21000030557963.shtml",
    "datetime": "2020-07-21 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：全资子公司检测试剂盒通过注册检验",
    "href": "http://stock.jrj.com.cn/2020/07/16220230264440.shtml",
    "datetime": "2020-07-16 22:02:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2020年上半年预计净利9000万元—1.2亿元同比下降 医院诊疗科室就诊人数下降",
    "href": "http://stock.jrj.com.cn/2020/07/15100730247529.shtml",
    "datetime": "2020-07-15 10:07:57",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：上半年归母净利润同比预降52%-64% 肝癌早筛项目落地在即",
    "href": "http://stock.jrj.com.cn/2020/07/15085430246207.shtml",
    "datetime": "2020-07-15 08:54:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15083030245774.shtml",
    "datetime": "2020-07-15 08:30:04",
    "code": "000710"
  },
  {
    "title": "贝瑞基因回复问询函：不存在利润调节情形",
    "href": "http://stock.jrj.com.cn/2020/07/03222330136993.shtml",
    "datetime": "2020-07-03 22:23:19",
    "code": "000710"
  },
  {
    "title": "贝瑞基因回复年报问询函：不存在利用关联交易调节利润情形",
    "href": "http://stock.jrj.com.cn/2020/07/03220130136919.shtml",
    "datetime": "2020-07-03 22:01:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：核酸检测预计日检测量达1万人次",
    "href": "http://stock.jrj.com.cn/2020/06/02133829826638.shtml",
    "datetime": "2020-06-02 13:38:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞十年 | 特殊时期的一级响应",
    "href": "http://stock.jrj.com.cn/2020/06/02000031623556.shtml",
    "datetime": "2020-06-02 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞十年 | 特殊时期的一级响应",
    "href": "http://stock.jrj.com.cn/2020/06/02000029871150.shtml",
    "datetime": "2020-06-02 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞十年 | 助理的二三事",
    "href": "http://stock.jrj.com.cn/2020/06/02000029871151.shtml",
    "datetime": "2020-06-02 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因推出“移动式核酸检测实验室” 为常态化疫情防控保驾护航",
    "href": "http://stock.jrj.com.cn/2020/06/02000029871152.shtml",
    "datetime": "2020-06-02 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞十年 | 心甘情愿的百万“代价”",
    "href": "http://stock.jrj.com.cn/2020/05/28000029871148.shtml",
    "datetime": "2020-05-28 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]和瑞基因推出黑色素瘤专用基因检测产品 突变检出率超90%",
    "href": "http://stock.jrj.com.cn/2020/05/28000029871147.shtml",
    "datetime": "2020-05-28 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：拟减资退出信念医药 聚焦主营业务",
    "href": "http://stock.jrj.com.cn/2020/05/27185129780405.shtml",
    "datetime": "2020-05-27 18:51:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞十年 | 国内首张NIPT延续注册证的背后",
    "href": "http://stock.jrj.com.cn/2020/05/27000029871149.shtml",
    "datetime": "2020-05-27 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞十年 | 被Deadline催生的大数据库创新",
    "href": "http://stock.jrj.com.cn/2020/05/26000029936797.shtml",
    "datetime": "2020-05-26 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]cSMART技术通过ctDNA监测有效克服新生抗原动态追踪难题",
    "href": "http://stock.jrj.com.cn/2020/05/11000029642279.shtml",
    "datetime": "2020-05-11 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2020年一季度盈利6239.33万 同比下降62.79%",
    "href": "http://stock.jrj.com.cn/2020/05/03102629491466.shtml",
    "datetime": "2020-05-03 10:26:30",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：一季度营业收入3.7亿元 同比增长11.14%",
    "href": "http://stock.jrj.com.cn/2020/04/28205529407767.shtml",
    "datetime": "2020-04-28 20:55:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：坚守核心业务 一季度营收增长11.14%",
    "href": "http://stock.jrj.com.cn/2020/04/28202629407265.shtml",
    "datetime": "2020-04-28 20:26:53",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2019年实现净利润3.91亿元 同比增长45.7%",
    "href": "http://stock.jrj.com.cn/2020/04/15100129293931.shtml",
    "datetime": "2020-04-15 10:01:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292311.shtml",
    "datetime": "2020-04-15 08:00:21",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2019年完美收官 肿瘤早筛将成2020年业务亮点",
    "href": "http://stock.jrj.com.cn/2020/04/14230129286963.shtml",
    "datetime": "2020-04-14 23:01:43",
    "code": "000710"
  },
  {
    "title": "贝瑞基因股东君睿祺拟减持1063.5万股 预计不超总股本2.99%",
    "href": "http://stock.jrj.com.cn/2020/04/13220429277310.shtml",
    "datetime": "2020-04-13 22:04:22",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：股东天津君睿祺拟减持不超2.99%股份",
    "href": "http://stock.jrj.com.cn/2020/04/13211529277047.shtml",
    "datetime": "2020-04-13 21:15:17",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：股东拟减持不超1063.5万股",
    "href": "http://stock.jrj.com.cn/2020/04/13175529275727.shtml",
    "datetime": "2020-04-13 17:55:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：股东天津君睿祺计划减持不超过2.99%公司股份",
    "href": "http://stock.jrj.com.cn/2020/04/13172729275501.shtml",
    "datetime": "2020-04-13 17:27:22",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]和瑞基因获CAP证书 基因检测能力达国际标准",
    "href": "http://stock.jrj.com.cn/2020/03/24000029366534.shtml",
    "datetime": "2020-03-24 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]杭州市副市长柯吉欣一行调研杭州贝瑞和康抗疫与复工工作",
    "href": "http://stock.jrj.com.cn/2020/03/12000029366533.shtml",
    "datetime": "2020-03-12 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]NIPT Plus近30万大数据新鲜出炉!",
    "href": "http://stock.jrj.com.cn/2020/03/11000029370125.shtml",
    "datetime": "2020-03-11 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因:每日完成1万份核酸检测 助力企业复工复产",
    "href": "http://stock.jrj.com.cn/2020/02/20000028868379.shtml",
    "datetime": "2020-02-20 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因为福州复工从业人员进行病毒核酸检测",
    "href": "http://stock.jrj.com.cn/2020/02/15124128833076.shtml",
    "datetime": "2020-02-15 12:41:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因为北京贝瑞使1亿元的综合授信提供连担保",
    "href": "http://stock.jrj.com.cn/2020/02/15094828832677.shtml",
    "datetime": "2020-02-15 09:48:45",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：拟受让子公司福建和瑞1.54%股权",
    "href": "http://stock.jrj.com.cn/2020/02/14201728831306.shtml",
    "datetime": "2020-02-14 20:17:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因推出高灵敏度三代测序试剂盒阻击新冠病毒变异",
    "href": "http://stock.jrj.com.cn/2020/02/09000028799320.shtml",
    "datetime": "2020-02-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：与中科院微生物所发力新冠病毒“潜伏期检测”",
    "href": "http://stock.jrj.com.cn/2020/02/01144728746911.shtml",
    "datetime": "2020-02-01 14:47:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因与中科院微生物所发力新冠病毒“潜伏期检测”",
    "href": "http://stock.jrj.com.cn/2020/02/01000028750283.shtml",
    "datetime": "2020-02-01 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]别眨眼!1分钟看完贝瑞基因的2019",
    "href": "http://stock.jrj.com.cn/2019/12/24000028580222.shtml",
    "datetime": "2019-12-24 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因首次回购公司股份28万股 占公司总股本的0.08%",
    "href": "http://stock.jrj.com.cn/2019/12/23220428574738.shtml",
    "datetime": "2019-12-23 22:04:14",
    "code": "000710"
  },
  {
    "title": "贝瑞基因将花不超3亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2019/11/21131328431626.shtml",
    "datetime": "2019-11-21 13:13:05",
    "code": "000710"
  },
  {
    "title": "贝瑞基因、包钢股份宣布数亿元回购计划",
    "href": "http://stock.jrj.com.cn/2019/11/21030528429297.shtml",
    "datetime": "2019-11-21 03:05:20",
    "code": "000710"
  },
  {
    "title": "贝瑞基因、包钢股份抛亿元回购计划 多上市公司已完成回购计划",
    "href": "http://stock.jrj.com.cn/2019/11/20212428428739.shtml",
    "datetime": "2019-11-20 21:24:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：拟斥资不超3亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/11/20203028428526.shtml",
    "datetime": "2019-11-20 20:30:47",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：拟不超3亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/11/20200528428445.shtml",
    "datetime": "2019-11-20 20:05:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因第三季度盈利6375.79万 同比减少31.52%",
    "href": "http://stock.jrj.com.cn/2019/10/31092228331233.shtml",
    "datetime": "2019-10-31 09:22:35",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2019年度净利润预增53%-64%",
    "href": "http://stock.jrj.com.cn/2019/10/30232828328726.shtml",
    "datetime": "2019-10-30 23:28:19",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2019年度净利同比预增53%-64%",
    "href": "http://stock.jrj.com.cn/2019/10/30225428328650.shtml",
    "datetime": "2019-10-30 22:54:43",
    "code": "000710"
  },
  {
    "title": "贝瑞基因预计全年净利同比增长53%-64%",
    "href": "http://stock.jrj.com.cn/2019/10/30211528328054.shtml",
    "datetime": "2019-10-30 21:15:39",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：预计全年净利同比增长53%-64%",
    "href": "http://stock.jrj.com.cn/2019/10/30202628327869.shtml",
    "datetime": "2019-10-30 20:26:40",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/30202028327844.shtml",
    "datetime": "2019-10-30 20:20:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因副总经理王冬辞职 2018年薪酬为71万元",
    "href": "http://stock.jrj.com.cn/2019/09/29174428196983.shtml",
    "datetime": "2019-09-29 17:44:54",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]PreCar前瞻性临床研究:肝癌早筛提前金标准6-12个月将成为现实",
    "href": "http://stock.jrj.com.cn/2019/09/26000028578963.shtml",
    "datetime": "2019-09-26 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因股东王冬减持28万股 套现约969万元",
    "href": "http://stock.jrj.com.cn/2019/09/22202628164438.shtml",
    "datetime": "2019-09-22 20:26:02",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]《证券日报》头版报导贝瑞基因:用“基因测序”服务健康中国",
    "href": "http://stock.jrj.com.cn/2019/09/14000028578964.shtml",
    "datetime": "2019-09-14 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]和瑞基因与上海市胸科医院联合成立国内首个大规模胸部肿瘤精准医学研究中心",
    "href": "http://stock.jrj.com.cn/2019/09/06000028578965.shtml",
    "datetime": "2019-09-06 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因与PacBio将联手推广第三代基因测序仪在临床的应用",
    "href": "http://stock.jrj.com.cn/2019/09/03000028578966.shtml",
    "datetime": "2019-09-03 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因2019半年报：净利大增七成，欲抢占行业龙头位置？",
    "href": "http://stock.jrj.com.cn/2019/08/29175228056902.shtml",
    "datetime": "2019-08-29 17:52:55",
    "code": "000710"
  },
  {
    "title": "贝瑞基因上半年净利同比大幅增长71.95%",
    "href": "http://stock.jrj.com.cn/2019/08/29114528054720.shtml",
    "datetime": "2019-08-29 11:45:35",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：持股14.55%的股东天津君睿祺拟减持不超5.5%",
    "href": "http://stock.jrj.com.cn/2019/08/22184628018178.shtml",
    "datetime": "2019-08-22 18:46:51",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：天津君睿祺拟减持公司不超5.5％股份",
    "href": "http://stock.jrj.com.cn/2019/08/22183228018107.shtml",
    "datetime": "2019-08-22 18:32:38",
    "code": "000710"
  },
  {
    "title": "贝瑞基因全资子公司收到《医疗器械注册证》",
    "href": "http://stock.jrj.com.cn/2019/08/16135727987365.shtml",
    "datetime": "2019-08-16 13:57:03",
    "code": "000710"
  },
  {
    "title": "专访｜贝瑞基因CEO周代星：基因检测行业已从“仪器竞争”迈入“场景竞争”",
    "href": "http://stock.jrj.com.cn/2019/08/15232927983809.shtml",
    "datetime": "2019-08-15 23:29:56",
    "code": "000710"
  },
  {
    "title": "“通德系”商业王国现状：手上的贝瑞基因股份再被冻结，钢铁资产连连易主",
    "href": "http://stock.jrj.com.cn/2019/07/09193127817917.shtml",
    "datetime": "2019-07-09 19:31:57",
    "code": "000710"
  },
  {
    "title": "贝瑞基因参与设立产业投资基金 加快全产业链战略布局",
    "href": "http://stock.jrj.com.cn/invest/2019/07/05090527800611.shtml",
    "datetime": "2019-07-05 09:05:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：公司与华为的合作地域主要在国内且经营一切正常",
    "href": "http://stock.jrj.com.cn/2019/06/18105027718892.shtml",
    "datetime": "2019-06-18 10:50:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因一季度净利1.68亿同比增长155% 现金流量净额-1671万",
    "href": "http://stock.jrj.com.cn/2019/05/06061427526600.shtml",
    "datetime": "2019-05-06 06:14:15",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/29210027509142.shtml",
    "datetime": "2019-04-29 21:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：预计上半年盈利2.35亿-2.7亿元",
    "href": "http://stock.jrj.com.cn/2019/04/29204127509077.shtml",
    "datetime": "2019-04-29 20:41:39",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2018年营业收入同比增长22.93% 布局向下游产业链延伸",
    "href": "http://stock.jrj.com.cn/2019/04/26234027494099.shtml",
    "datetime": "2019-04-26 23:40:31",
    "code": "000710"
  },
  {
    "title": "贝瑞基因盈利稳升NIPT检测超300万 创新、应用双管齐下研发再增132％",
    "href": "http://stock.jrj.com.cn/2019/04/25094627479768.shtml",
    "datetime": "2019-04-25 09:46:18",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2018年营业收入同比增长22.93% 布局向下游产业链延伸",
    "href": "http://stock.jrj.com.cn/2019/04/24224027476660.shtml",
    "datetime": "2019-04-24 22:40:24",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/14224027388300.shtml",
    "datetime": "2019-04-14 22:40:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2019年度第一季度盈利同比预增147％-170％",
    "href": "http://stock.jrj.com.cn/2019/04/14165527386107.shtml",
    "datetime": "2019-04-14 16:55:46",
    "code": "000710"
  },
  {
    "title": "贝瑞基因一季度净利润预增147%-170%",
    "href": "http://stock.jrj.com.cn/2019/04/14162027390088.shtml",
    "datetime": "2019-04-14 16:20:34",
    "code": "000710"
  },
  {
    "title": "贝瑞基因控股子公司引入战略投资者 肿瘤基因检测业务获力挺",
    "href": "http://stock.jrj.com.cn/2019/03/14164127167143.shtml",
    "datetime": "2019-03-14 16:41:41",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：预计2018年盈利3.2亿元至3.4亿元",
    "href": "http://stock.jrj.com.cn/2019/01/29224126998833.shtml",
    "datetime": "2019-01-29 22:41:51",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2018年净利预增31%-39%",
    "href": "http://stock.jrj.com.cn/2019/01/29205226998404.shtml",
    "datetime": "2019-01-29 20:52:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/29205026998398.shtml",
    "datetime": "2019-01-29 20:50:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因董事长高扬：基因数据未来或是公司最核心资产",
    "href": "http://stock.jrj.com.cn/2018/11/18184425368420.shtml",
    "datetime": "2018-11-18 18:44:30",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：拟共同投资设立北京圆基因",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/09075925321746.shtml",
    "datetime": "2018-11-09 07:59:58",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：拟进入消费级基因检测领域",
    "href": "http://stock.jrj.com.cn/2018/11/08220325320347.shtml",
    "datetime": "2018-11-08 22:03:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因前三季度净利增近五成",
    "href": "http://stock.jrj.com.cn/2018/10/30171125281036.shtml",
    "datetime": "2018-10-30 17:11:15",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：总经理拟增持不超过3000万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/17075925214278.shtml",
    "datetime": "2018-10-17 07:59:59",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：公司总经理拟增持股份",
    "href": "http://stock.jrj.com.cn/2018/10/16203525211698.shtml",
    "datetime": "2018-10-16 20:35:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：拟发行不超4亿元债权融资计划",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/27075925142659.shtml",
    "datetime": "2018-09-27 07:59:57",
    "code": "000710"
  },
  {
    "title": "贝瑞基因上半年净利增50% 研发投入同比增长49.33%",
    "href": "http://stock.jrj.com.cn/2018/08/22020424983526.shtml",
    "datetime": "2018-08-22 02:04:12",
    "code": "000710"
  },
  {
    "title": "贝瑞基因前三季预增26%-43% 半年报增长五成",
    "href": "http://stock.jrj.com.cn/2018/08/21212124982839.shtml",
    "datetime": "2018-08-21 21:21:15",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/21203024982654.shtml",
    "datetime": "2018-08-21 20:30:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因预增超20倍 明日披露半年报",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/21164724981847.shtml",
    "datetime": "2018-08-21 16:47:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：终止投资美国百纳基因可转换债券",
    "href": "http://stock.jrj.com.cn/2018/07/30190524880280.shtml",
    "datetime": "2018-07-30 19:05:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因董事长高扬:一管血和一管羊水的价值",
    "href": "http://stock.jrj.com.cn/2018/07/09000027920644.shtml",
    "datetime": "2018-07-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞基因董事长高扬:一管血和一管羊水的价值",
    "href": "http://stock.jrj.com.cn/2018/07/09000025452171.shtml",
    "datetime": "2018-07-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]重磅!和瑞基因大动作",
    "href": "http://stock.jrj.com.cn/2018/07/09000025452173.shtml",
    "datetime": "2018-07-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]重磅!和瑞基因大动作",
    "href": "http://stock.jrj.com.cn/2018/07/09000027920643.shtml",
    "datetime": "2018-07-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]cSMART技术首登世界肺癌大会,壁报展示获重点点评",
    "href": "http://stock.jrj.com.cn/2018/07/09000025452169.shtml",
    "datetime": "2018-07-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]cSMART技术首登世界肺癌大会,壁报展示获重点点评",
    "href": "http://stock.jrj.com.cn/2018/07/09000027920642.shtml",
    "datetime": "2018-07-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]cSMART技术首登世界肺癌大会,壁报展示获重点点评",
    "href": "http://stock.jrj.com.cn/2018/07/09000028927912.shtml",
    "datetime": "2018-07-09 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]磨练海量基因数据的处理能力",
    "href": "http://stock.jrj.com.cn/2018/06/14000027920641.shtml",
    "datetime": "2018-06-14 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]磨练海量基因数据的处理能力",
    "href": "http://stock.jrj.com.cn/2018/06/14000025452170.shtml",
    "datetime": "2018-06-14 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因牵手周大福 加快国际化步伐",
    "href": "http://stock.jrj.com.cn/2018/05/22051624570906.shtml",
    "datetime": "2018-05-22 05:16:17",
    "code": "000710"
  },
  {
    "title": "贝瑞基因放量跌停 两机构抛售3052万元",
    "href": "http://stock.jrj.com.cn/2018/05/11194024528752.shtml",
    "datetime": "2018-05-11 19:40:00",
    "code": "000710"
  },
  {
    "title": "医药板块表现惨淡 贝瑞基因股价跌停",
    "href": "http://stock.jrj.com.cn/2018/05/11133724526827.shtml",
    "datetime": "2018-05-11 13:37:11",
    "code": "000710"
  },
  {
    "title": "贝瑞基因拟500万美元投资美国百纳基因可转债",
    "href": "http://stock.jrj.com.cn/2018/04/16220824397658.shtml",
    "datetime": "2018-04-16 22:08:19",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：一季度预计扭亏 净利6000万元–8000万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/13075924384420.shtml",
    "datetime": "2018-04-13 07:59:54",
    "code": "000710"
  },
  {
    "title": "贝瑞基因：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/12180024381996.shtml",
    "datetime": "2018-04-12 18:00:00",
    "code": "000710"
  },
  {
    "title": "五粮液看高百元 贝瑞基因或涨四成",
    "href": "http://stock.jrj.com.cn/2018/04/12004524377461.shtml",
    "datetime": "2018-04-12 00:45:14",
    "code": "000710"
  },
  {
    "title": "天齐锂业贝瑞基因被踏破门槛",
    "href": "http://stock.jrj.com.cn/2017/12/28110723863918.shtml",
    "datetime": "2017-12-28 11:07:10",
    "code": "000710"
  },
  {
    "title": "超百家机构调研 天齐锂业贝瑞基因被踏破门槛",
    "href": "http://stock.jrj.com.cn/2017/12/28004323860721.shtml",
    "datetime": "2017-12-28 00:43:25",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]CSCO年会中,一场真正“精”天“动”地的卫星会",
    "href": "http://stock.jrj.com.cn/2017/10/11000024506961.shtml",
    "datetime": "2017-10-11 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]2017中国出生缺陷防控论坛:分子时代产前诊断新技术新思路",
    "href": "http://stock.jrj.com.cn/2017/09/26000024506953.shtml",
    "datetime": "2017-09-26 00:00:00",
    "code": "000710"
  },
  {
    "title": "贝瑞基因尾盘跌停 主力大举出逃",
    "href": "http://stock.jrj.com.cn/2017/09/15145523121084.shtml",
    "datetime": "2017-09-15 14:55:00",
    "code": "000710"
  },
  {
    "title": "游资炒作 贝瑞基因三天两涨停",
    "href": "http://stock.jrj.com.cn/2017/09/14104523112290.shtml",
    "datetime": "2017-09-14 10:45:56",
    "code": "000710"
  },
  {
    "title": "申请撤销退市风险警示并更名为贝瑞基因 *ST天仪涨停",
    "href": "http://stock.jrj.com.cn/2017/08/21093322969802.shtml",
    "datetime": "2017-08-21 09:33:39",
    "code": "000710"
  },
  {
    "title": "*ST天仪拟更名 两大基因巨头聚首",
    "href": "http://stock.jrj.com.cn/2017/08/21035322968798.shtml",
    "datetime": "2017-08-21 03:53:52",
    "code": "000710"
  },
  {
    "title": "*ST天仪：申请撤销退市风险警示并更名为贝瑞基因",
    "href": "http://stock.jrj.com.cn/2017/08/21020222968423.shtml",
    "datetime": "2017-08-21 02:02:06",
    "code": "000710"
  },
  {
    "title": "*ST天仪：申请撤销退市风险警示并更名为“贝瑞基因”",
    "href": "http://stock.jrj.com.cn/2017/08/20182022969995.shtml",
    "datetime": "2017-08-20 18:20:00",
    "code": "000710"
  },
  {
    "title": "华大基因开板上演“隔山打牛” *ST天仪跌停",
    "href": "http://stock.jrj.com.cn/2017/08/09100522868318.shtml",
    "datetime": "2017-08-09 10:05:33",
    "code": "000710"
  },
  {
    "title": "*ST天仪：2017年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/07/14164022750568.shtml",
    "datetime": "2017-07-14 16:40:04",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]进击2017!科诺安临床深度交流会·南宁站",
    "href": "http://stock.jrj.com.cn/2017/06/08000024506959.shtml",
    "datetime": "2017-06-08 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]会议速递|于福利教授:流产物遗传分析揭示早期发育关键基因",
    "href": "http://stock.jrj.com.cn/2017/05/28000024506958.shtml",
    "datetime": "2017-05-28 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]会议速递|周代星博士:一管血实现遗传病全覆盖的无创产前检测",
    "href": "http://stock.jrj.com.cn/2017/05/28000024506960.shtml",
    "datetime": "2017-05-28 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]2017年昂科益4月城市系列论坛|贝瑞和康cSMART二代测序技术受到临床肿瘤专家的高度认可",
    "href": "http://stock.jrj.com.cn/2017/05/08000024506956.shtml",
    "datetime": "2017-05-08 00:00:00",
    "code": "000710"
  },
  {
    "title": "*ST天仪及西藏城投并购重组26日上会",
    "href": "http://stock.jrj.com.cn/2017/04/20204522357425.shtml",
    "datetime": "2017-04-20 20:45:41",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]第三届中国母胎医学大会:带领高通量测序技术临床应用驶入新蓝海",
    "href": "http://stock.jrj.com.cn/2017/04/18000024506957.shtml",
    "datetime": "2017-04-18 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞和康:用二代测序和三代测序构建遗传病检测新维度",
    "href": "http://stock.jrj.com.cn/2017/04/17000024506955.shtml",
    "datetime": "2017-04-17 00:00:00",
    "code": "000710"
  },
  {
    "title": "*ST天仪现拟调整本次重大资产重组方案继续停牌",
    "href": "http://stock.jrj.com.cn/2017/04/12121622301480.shtml",
    "datetime": "2017-04-12 12:16:01",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]进击2017!科诺安临床深度交流会·北京站",
    "href": "http://stock.jrj.com.cn/2017/03/30000024506966.shtml",
    "datetime": "2017-03-30 00:00:00",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]【会议播报】贝瑞和康携遗传性妇科肿瘤基因检测,惊艳亮相泉城",
    "href": "http://stock.jrj.com.cn/2017/03/30000024506954.shtml",
    "datetime": "2017-03-30 00:00:00",
    "code": "000710"
  },
  {
    "title": "有望被贝瑞和康借壳 *ST天仪6日5涨停",
    "href": "http://stock.jrj.com.cn/2017/03/20094622198238.shtml",
    "datetime": "2017-03-20 09:46:32",
    "code": "000710"
  },
  {
    "title": "贝瑞和康借壳案引关注 *ST天仪十万字回复证监会意见",
    "href": "http://stock.jrj.com.cn/2017/03/09201822158343.shtml",
    "datetime": "2017-03-09 20:18:33",
    "code": "000710"
  },
  {
    "title": "天兴仪表预计2016年继续亏损 或被ST",
    "href": "http://stock.jrj.com.cn/2017/01/23174822002241.shtml",
    "datetime": "2017-01-23 17:48:36",
    "code": "000710"
  },
  {
    "title": "[贝瑞基因]贝瑞和康亮相全球第35届JPM健康大会, NIPT及cSMART等备受关注",
    "href": "http://stock.jrj.com.cn/2017/01/17000024506964.shtml",
    "datetime": "2017-01-17 00:00:00",
    "code": "000710"
  },
  {
    "title": "天兴仪表高处不胜寒 股价封上跌停",
    "href": "http://stock.jrj.com.cn/2017/01/11133221954894.shtml",
    "datetime": "2017-01-11 13:32:43",
    "code": "000710"
  },
  {
    "title": "4日上市公司停复牌：天兴仪表核查无异常将复牌",
    "href": "http://stock.jrj.com.cn/2017/01/03172721920648.shtml",
    "datetime": "2017-01-03 17:27:49",
    "code": "000710"
  },
  {
    "title": "天兴仪表股票交易异常波动 29日起停牌核查",
    "href": "http://stock.jrj.com.cn/2016/12/28165621901130.shtml",
    "datetime": "2016-12-28 16:56:41",
    "code": "000710"
  },
  {
    "title": "天兴仪表作价43亿购贝瑞和康 复牌连续8日涨停",
    "href": "http://stock.jrj.com.cn/2016/12/28093121897860.shtml",
    "datetime": "2016-12-28 09:31:20",
    "code": "000710"
  },
  {
    "title": "天兴仪表作价43亿购贝瑞和康 复牌连续6日涨停",
    "href": "http://stock.jrj.com.cn/2016/12/26092921885179.shtml",
    "datetime": "2016-12-26 09:29:15",
    "code": "000710"
  },
  {
    "title": "天兴仪表：作价43亿元购贝瑞和康 股价有望上涨",
    "href": "http://stock.jrj.com.cn/2016/12/04221321789679.shtml",
    "datetime": "2016-12-04 22:13:10",
    "code": "000710"
  },
  {
    "title": "天兴仪表：作价43亿元购贝瑞和康 复牌上涨概率非常大",
    "href": "http://stock.jrj.com.cn/2016/12/04221321789680.shtml",
    "datetime": "2016-12-04 22:13:10",
    "code": "000710"
  },
  {
    "title": "多家上市川企连亏 何时是个头？",
    "href": "http://stock.jrj.com.cn/2016/10/26225121624046.shtml",
    "datetime": "2016-10-26 22:51:27",
    "code": "000710"
  },
  {
    "title": "天兴仪表重组前景尚待验证",
    "href": "http://stock.jrj.com.cn/2016/08/17231121332508.shtml",
    "datetime": "2016-08-17 23:11:09",
    "code": "000710"
  },
  {
    "title": "天兴仪表预计去年净利润亏损1150-1350万元",
    "href": "http://stock.jrj.com.cn/2016/01/28194020503133.shtml",
    "datetime": "2016-01-28 19:40:27",
    "code": "000710"
  },
  {
    "title": "天兴仪表业绩亏损768万 罗广伟举牌就是赌乌鸡变凤凰",
    "href": "http://stock.jrj.com.cn/2015/11/26115020138534.shtml",
    "datetime": "2015-11-26 11:50:53",
    "code": "000710"
  },
  {
    "title": "天兴仪表股东增持减持",
    "href": "http://stock.jrj.com.cn/2015/11/16004020073914.shtml",
    "datetime": "2015-11-16 00:40:12",
    "code": "000710"
  },
  {
    "title": "新价值投资举牌天兴仪表",
    "href": "http://stock.jrj.com.cn/2015/11/15191120073672.shtml",
    "datetime": "2015-11-15 19:11:03",
    "code": "000710"
  },
  {
    "title": "天兴仪表设金融贸易服务类子公司",
    "href": "http://stock.jrj.com.cn/2015/11/13084520065812.shtml",
    "datetime": "2015-11-13 08:45:56",
    "code": "000710"
  },
  {
    "title": "天兴仪表 一季度至少亏损500万元",
    "href": "http://stock.jrj.com.cn/2015/04/14082219095794.shtml",
    "datetime": "2015-04-14 08:22:07",
    "code": "000710"
  }
]